Staphylococcus aureus: The multi headed hydra resists and controls human complement response in multiple ways

International Journal of Medical Microbiology

Volumn 304, Issue 2, 2014, Pages 188-194

  Zipfel, Peter F ^a,b   Skerka, Christine ^a  

^a HANS KNÖLL INSTITUTE   (Germany)

^b FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

Complement; Immune escape pathogenic bacteria

Indexed keywords

COMPLEMENT; IMMUNE ESCAPE PATHOGENIC BACTERIA;

ANIMALS; COMPLEMENT SYSTEM PROTEINS; HUMANS; IMMUNE EVASION; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 84893813150     PISSN: 14384221     EISSN: 16180607     Source Type: Journal    
DOI: 10.1016/j.ijmm.2013.11.004     Document Type: Short Survey

References (63)

1. Barthel D., Schindler S., Zipfel P.F. Plasminogen is a complement inhibitor. J. Biol. Chem. 2012, 287:18831-18842.
2. Bergmann S., Hammerschmidt S. Fibrinolysis and host response in bacterial infections. Thromb. Haemost. 2007, 98:512-520.
3. Bestebroer J., Aerts P.C., Rooijakkers S.H., Pandey M.K., Köhl J., van Strijp J.A., de Haas C.J. Functional basis for complement evasion by staphylococcal superantigen-like 7. Cell. Microbiol. 2010, 12:1506-1516.
4. Bokarewa M.I., Jin T., Tarkowski A. Staphylococcus aureus: staphylokinase. Int. J. Biochem. Cell. Biol. 2006, 38:504-509.
5. Burman J.D., Leung E., Atkins K.L., O'Seaghdha M.N., Lango L., Bernadó P., Bagby S., Svergun D.I., Foster T.J., Isenman D.E., van den Elsen J.M. Interaction of human complement with Sbi, a staphylococcal immunoglobulin-binding protein: indications of a novel mechanism of complement evasion by Staphylococcus aureus. J. Biol. Chem. 2008, 283:17579-17593.
6. Chen H., Ricklin D., Hammel M., Garcia B.L., McWhorter W.J., Sfyroera G., Wu Y.Q., Tzekou A., Li S., Geisbrecht B.V., Woods V.L., Lambris J.D. Allosteric inhibition of complement function by a staphylococcal immune evasion protein. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:17621-17626.
7. Chhatwal G.S., Preissner K.T., Müller-Berghaus G., Blobel H. Specific binding of the human S protein (vitronectin) to streptococci Staphylococcus aureus, and Escherichia coli. Infect. Immun. 1987, 55:1878-1883.
8. Foster T.J. Immune evasion by staphylococci. Nat. Rev. Microbiol. 2005, 3:948-958.
9. Furuya H., Ikeda R. Interaction of triosephosphate isomerase from Staphylococcus aureus with plasminogen. Microbiol. Immunol. 2011, 55:855-862.
10. Garred P., Honoré C., Ma Y.J., Rørvig S., Cowland J., Borregaard N., Hummelshøj T. The genetics of ficolins. J. Innate Immun. 2010, 2:3-16.
11. Garcia B.L., Ramyar K.X., Ricklin D., Lambris J.D., Geisbrecht B.V. Advances in understanding the structure, function, and mechanism of the SCIN and Efb families of Staphylococcal immune evasion proteins. Adv. Exp. Med. Biol. 2012, 946:113-133.
12. Gould I.M., David M.Z., Esposito S., Garau J., Lina G., Mazzei T., Peters G. New insights into methicillin-resistant Staphylococcus aureus (MRSA) pathogenesis, treatment and resistance. Int. J. Antimicrob. Agents 2012, 39:96-104.
13. Gropp K., Weber N., Reuter M., Micklisch S., Kopka I., Hallström T., Skerka C. β2-Glycoprotein I, the major target in antiphospholipid syndrome, is a special human complement regulator. Blood 2011, 118:2283-2774.
14. Grumann D., Scharf S.S., Holtfreter S., Kohler C., Steil L., Engelmann S., Hecker M., Völker U., Bröker B.M. Immune cell activation by enterotoxin gene cluster (egc)-encoded and non-egc superantigens from Staphylococcus aureus. J. Immunol. 2008, 181:5054-5061.
15. Hair P.S., Wagner S.M., Friederich P.T., Drake R.R., Nyalwidhe J.O., Cunnion K.M. Complement regulator C4BP binds to Staphylococcus aureus and decreases opsonization. Mol. Immunol. 2012, 50:253-261.
16. Hair P.S., Ward M.D., Semmes O.J., Foster T.J., Cunnion K.M. Staphylococcus aureus clumping factor A binds to complement regulator factor I and increases factor I cleavage of C3b. J. Infect. Dis. 2008, 198:125-133.
17. Hammel M., Sfyroera G., Pyrpassopoulos S., Ricklin D., Ramyar K.X., Pop M., Jin Z., Lambris J.D., Geisbrecht B.V. Characterization of Ehp, a secreted complement inhibitory protein from Staphylococcus aureus. J. Biol. Chem. 2007, 282:30051-30061.
18. Hammel M., Sfyroera G., Ricklin D., Magotti P., Lambris J.D., Geisbrecht B.V. A structural basis for complement inhibition by Staphylococcus aureus. Nat. Immunol. 2007, 8:430-437.
19. Hartleib J., Köhler N., Dickinson R.B., Chhatwal G.S., Sixma J.J., Hartford O.M., Foster T.J., Peters G., Kehrel B.E., Herrmann M. Protein A is the von Willebrand factor binding protein on Staphylococcus aureus. Blood 2000, 96:2149-2156.
20. Haupt K., Reuter M., van den Elsen J., Burman J., Hälbich S., Richter J., Skerka C., Zipfel P.F. The Staphylococcus aureus protein Sbi acts as a complement inhibitor and forms a tripartite complex with host complement Factor H and C3b. PLoS Pathog. 2008, 4:e1000250.
21. Hecker M., Becher D., Fuchs S., Engelmann S. A proteomic view of cell physiology and virulence of Staphylococcus aureus. Int. J. Med. Microbiol. 2010, 300:76-87.
22. Hussain M., Becker K., von Eiff C., Schrenzel J., Peters G., Herrmann M. Identification and characterization of a novel 38.5-kilodalton cell surface protein of Staphylococcus aureus with extended-spectrum binding activity for extracellular matrix and plasma proteins. J. Bacteriol. 2001, 183:6778-6786.
23. Isenman D.E., Leung E., Mackay J.D., Bagby S., van den Elsen J.M. Mutational analyses reveal that the staphylococcal immune evasion molecule Sbi and complement receptor 2 (CR2) share overlapping contact residues on C3d: implications for the controversy regarding the CR2/C3d cocrystal structure. J. Immunol. 2010, 184:1946-1955.
24. Itoh S., Hamada E., Kamoshida G., Yokoyama R., Takii T., Onozaki K., Tsuji T. Staphylococcal superantigen-like protein 10 (SSL10) binds to human immunoglobulin G (IgG) and inhibits complement activation via the classical pathway. Mol. Immunol. 2010, 47:932-938.
25. Jongerius I., Köhl J., Pandey M.K., Ruyken M., van Kessel K.P., van Strijp J.A., Rooijakkers S.H. Staphylococcal complement evasion by various convertase-blocking molecules. J. Exp. Med. 2007, 204:2461-2471.
26. Jung D.J., An J.H., Kurokawa K., Jung Y.C., Kim M.J., Aoyagi Y., Matsushita M., Takahashi S., Lee H.S., Takahashi K., Lee B.L. Specific serum Ig recognizing staphylococcal wall teichoic acid induces complement-mediated opsonophagocytosis against Staphylococcus aureus. J. Immunol. 2012, 189:4951-4959.
27. Kang M., Ko Y.P., Liang X., Ross C.L., Liu Q., Murray B.E., Höök M. Collagen-binding MSCRAMMs of Gram-positive bacteria inhibit complement activation via the classical pathway. J. Biol. Chem. 2013, 288:20520-20531.
28. Kilgore K.S., Flory C.M., Miller B.F., Evans V.M., Warren J.S. The membrane attack complex of complement induces interleukin-8 and monocyte chemoattractant protein-1 secretion from human umbilical vein endothelial cells. Am. J. Pathol. 1996, 149:953-961.
29. Klos A., Tenner A.J., Johswich K.O., Ager R.R., Reis E.S., Köhl J. The role of the anaphylatoxins in health and disease. Mol. Immunol. 2009, 46:2753-2766.
30. Koch T.K., Reuter M., Barthel D., Böhm S., van den Elsen J., Kraiczy P., Zipfel P.F., Skerka C. Staphylococcus aureus proteins Sbi and Efb recruit human plasmin to degrade complement C3 and C3b. PLoS ONE 2012, 7:e47638.
31. Köhl J. Self, non-self, and danger: a complementary view. Adv. Exp. Med. Biol. 2006, 586:71-94.
32. Kraus D., Peschel A. Staphylococcus aureus evasion of innate antimicrobial defense. Future Microbiol. 2008, 3:437-451.
33. Kwieciński J., Josefsson E., Mitchell J., Higgins J., Magnusson M., Foster T., Jin T., Bokarewa M. Activation of plasminogen by staphylokinase reduces the severity of Staphylococcus aureus systemic infection. J. Infect. Dis. 2010, 202:1041-1049.
34. Laarman A.J., Ruyken M., Malone C.L., van Strijp J.A., Horswill A.R., Rooijakkers S.H. Staphylococcus aureus metalloprotease aureolysin cleaves complement C3 to mediate immune evasion. J. Immunol. 2011, 186:6445-6653.
35. Liang O.D., Flock J.I., Wadström T. Isolation and characterisation of a vitronectin-binding surface protein from Staphylococcus aureus. Biochem. Biophys. Acta 1995, 1250:110-116.
36. Mantovani A., Valentino S., Gentile S., Inforzato A., Bottazzi B., Garlanda C. The long pentraxin PTX3: a paradigm for humoral pattern recognition molecules. Ann. N. Y. Acad. Sci. 2013, 1285:1-14.
37. Malmsten M., Schmidtchen A. Antimicrobial C3a - biology, biophysics, and evolution. Adv. Exp. Med. Biol. 2007, 598:141-158.
38. Mihlan M., Blom A.M., Kupreishvili K., Lauer N., Stelzner K., Bergström F., Niessen H.W., Zipfel P.F. Monomeric C-reactive protein modulates classic complement activation on necrotic cells. FASEB J. 2011, 25:4198-4210.
39. Mihlan M., Stippa S., Józsi M., Zipfel P.F. Monomeric CRP contributes to complement control in fluid phase and on cellular surfaces and increases phagocytosis by recruiting factor H. Cell Death Differ. 2009, 16:1630-1640.
40. Palma M., Wade D., Flock M., Flock J.I. Multiple binding sites in the interaction between an extracellular fibrinogen-binding protein from staphylococcus aureus and fibrinogen. J. Biol. Chem. 1998, 273:13177-13181.
41. Pangburn M.K., Schreiber R.D., Müller-Eberhard H.J. C3b deposition during activation of the alternative complement pathway and the effect of deposition on the activating surface. J. Immunol. 1983, 131:1930-1935.
42. Reuter M., Zipfel P.F. Complement activation products C3a and C4a as endogenous antimicrobial peptides. Int. J. Peptid. Res. Therap. 2009, 15:87-95.
43. Ricklin D., Ricklin-Lichtsteiner S.K., Markiewski M.M., Geisbrecht B.V., Lambris J.D. Cutting edge: members of the Staphylococcus aureus extracellular fibrinogen-binding protein family inhibit the interaction of C3d with complement receptor 2. J. Immunol. 2008, 181:7463-7467.
44. Rooijakkers S.H., Ruyken M., Roos A., Daha M.R., Presanis J.S., Sim R.B., van Wamel W.J., van Kessel K.P., van Strijp J.A. Immune evasion by a staphylococcal complement inhibitor that acts on C3 convertases. Nat. Immunol. 2005, 6:920-927.
45. Rooijakkers S.H., van Kessel K.P., van Strijp J.A. Staphylococcal innate immune evasion. Trends Microbiol. 2005, 13:596-601.
46. Rooijakkers S.H., van Strijp J.A. Bacterial complement evasion. Mol. Immunol. 2007, 44:23-32.
47. Sarma J.V., Ward P.A. New developments in C5a receptor signaling. Cell Health Cytoskelet. 2012, 4:73-82.
48. Serruto D., Rappuoli R., Scarselli M., Gros P., van Strijp J.A. Molecular mechanisms of complement evasion: learning from staphylococci and meningococci. Nat. Rev. Microbiol. 2010, 8:393-399.
49. Sharp J.A., Echague C.G., Hair P.S., Ward M.D., Nyalwidhe J.O., Geoghegan J.A., Foster T.J., Cunnion K.M. Staphylococcus aureus surface protein SdrE binds complement regulator factor H as an immune evasion tactic. PLoS ONE 2012, 7:e38407.
50. Smith E.J., Corrigan R.M., van der Sluis T., Gründling A., Speziale P., Geoghegan J.A., Foster T.J. The immune evasion protein Sbi of Staphylococcus aureus occurs both extracellularly and anchored to the cell envelope by binding lipoteichoic acid. Mol. Microbiol. 2012, 83:789-804.
51. Song W.C. Crosstalk between complement and toll-like receptors. Toxicol. Pathol. 2012, 40:174-182.
52. Spaan A.N., Henry T., van Rooijen W.J., Perret M., Badiou C., Aerts P.C., Kemmink J., de Haas C.J., van Kessel K.P., Vandenesch F., Lina G., van Strijp J.A. The staphylococcal toxin panton-valentine leukocidin targets human c5a receptors. Cell Host Microbe 2013, 13(May (5)):584-594. 10.1016/j.chom.2013.04.006.
53. Tedesco F., Pausa M., Nardon E., Introna M., Mantovani A., Dobrina A. The cytolytically inactive terminal complement complex activates endothelial cells to express adhesion molecules and tissue factor procoagulant activity. J. Exp. Med. 1997, 185:1619-1627.
54. Thurman J.M., Holers V.M. The central role of the alternative complement pathway in human disease. J. Immunol. 2006, 176:1305-1310.
55. Upadhyay A., Burman J.D., Clark E.A., Leung E., Isenman D.E., van den Elsen J.M., Bagby S. Structure-function analysis of the C3 binding region of Staphylococcus aureus immune subversion protein Sbi. J. Biol. Chem. 2008, 283:22113-22120.
56. Walport M.J. Complement. First of two parts. N. Engl. J. Med. 2001, 344:1058-1066.
57. Zecconi A., Scali F. Staphylococcus aureus virulence factors in evasion from innate immune defenses in human and animal diseases. Immunol. Lett. 2013, 150:12-22.
58. Zhang L., Jacobsson K., Vasi J., Lindberg M., Frykberg L. A second IgG-binding protein in Staphylococcus aureus. Microbiology 1998, 144:985-991.
59. Zipfel P.F., Würzner R., Skerka C. Complement evasion of pathogens: common strategies are shared by diverse organisms. Mol. Immunol. 2007, 44:3850-3857.
60. Zipfel P.F. Complement and immune defense: from innate immunity to human diseases. Immunol. Lett. 2009, 126:1-7.
61. Zipfel P.F., Skerka C. Complement regulators and inhibitory proteins. Nat. Rev. Immunol. 2009, 9:729-740.
62. Zipfel P.F., Skerka C. Complement Candida and cytokines: the role of C5a in host response to fungi. Eur. J. Immunol. 2012, 42:822-825.
63. Zipfel P.F., Hallström T., Riesbeck K. Human complement control and complement evasion by pathogenic microbes - tipping the balance. Mol. Immunol. 2013, 56:152-160.